Antithymocyte globulin
Showing 51 - 75 of 632
Stem Cell Transplantation, Leukemia Trial in Houston (Plerixafor, Filgrastim, Fludarabine)
Completed
- Stem Cell Transplantation
- Leukemia
- Plerixafor
- +5 more
-
Houston, TexasUT MD Anderson Cancer Center
Sep 22, 2020
Severe Aplastic Anemia Trial in United States (drug, radiation, procedure)
Completed
- Severe Aplastic Anemia
- Antithymocyte Globulin (ATG)
- +7 more
-
Duarte, California
- +27 more
Jul 21, 2022
Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Myeloid Leukemia Trial in Houston (Clofarabine, Busulfan, Fludarabine)
Completed
- Acute Myeloid Leukemia
- +2 more
- Clofarabine
- +5 more
-
Houston, TexasUT MD Anderson Cancer Center
Jan 6, 2021
Refractory Non Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma Trial in Sacramento (biological, radiation, procedure, drug)
Active, not recruiting
- Refractory Non Hodgkin Lymphoma
- Relapsed Non Hodgkin Lymphoma
- rituximab
- +7 more
-
Sacramento, CaliforniaUniversity of California Davis
Nov 28, 2022
Systemic Lupus Erythematosus Trial in Chicago (Hematopoietic stem cell transplantation)
Completed
- Systemic Lupus Erythematosus
- Hematopoietic stem cell transplantation
-
Chicago, Illinois
- +1 more
Feb 17, 2020
MDS Trial in Canada, United States (anti-thymocyte globulin)
Completed
- Myelodysplastic Syndromes
- anti-thymocyte globulin
-
Washington, District of Columbia
- +27 more
Jan 24, 2021
Kidney Transplantation, Immunosuppression Trial in Cincinnati (Tacrolimus Extended Release Oral Tablet [Envarsus], Mycophenolate
Unknown status
- Kidney Transplantation
- Immunosuppression
- Tacrolimus Extended Release Oral Tablet [Envarsus]
- +6 more
-
Cincinnati, Ohio
- +1 more
May 12, 2020
Sickle Cell Disease Trial in United States (Busulfan, Fludarabine, r-ATG)
Active, not recruiting
- Sickle Cell Disease
- Busulfan
- +11 more
-
Oakland, California
- +34 more
Sep 21, 2022
Stem Cell Transplantation, Leukemia, Lymphoma Trial in Houston (Thiotepa, Clofarabine, Busulfan)
Completed
- Stem Cell Transplantation
- +2 more
- Thiotepa
- +9 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Mar 25, 2020
Leukemia, Lymphoma Trial in Houston (Rituximab, 111In Ibritumomab, Planar Scintigraphy Imaging)
Completed
- Leukemia
- Lymphoma
- Rituximab
- +11 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Apr 23, 2020
Myelodysplastic Syndrome, Leukemia Trial in Houston (procedure, drug, other, radiation)
Completed
- Myelodysplastic Syndrome
- Leukemia
- Cord Blood Infusion
- +11 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Feb 27, 2020
Kidney Transplant Rejection, Kidney Transplant; Complications Trial in Veracruz (Basiliximab, Thymoglobulin)
Completed
- Kidney Transplant Rejection
- Kidney Transplant; Complications
-
Veracruz, MexicoUmae Hospital Especialidades 14 Adolfo Ruiz Cortines
Nov 14, 2019
Renal Transplant Rejection, Induction Therapy Trial (Rabbit Anti thymocyte globulin (rATG), Basiliximab)
Not yet recruiting
- Renal Transplant Rejection
- Induction Therapy
- Rabbit Anti thymocyte globulin (rATG)
- Basiliximab
- (no location specified)
Sep 22, 2022
Acute Leukemia, Chronic Myeloid Leukemia, Myelodysplastic Syndrome Trial in Guangzhou (HSCT from MSD, HSCT from MUD, HSCT from
Completed
- Acute Leukemia
- +2 more
- HSCT from MSD
- +6 more
-
Guangzhou, Guangdong, ChinaDepartment of Hematology,Nanfang Hospital, Southern Medical Univ
Mar 3, 2020
Multiple Sclerosis, Relapsing-Remitting Trial in La Jolla (Autologous hematopoietic stem cell transplantation,
Recruiting
- Multiple Sclerosis, Relapsing-Remitting
- Autologous hematopoietic stem cell transplantation
- +2 more
-
La Jolla, CaliforniaScripps Green Hospital
Aug 16, 2022
Scleroderma, Cardiac Involvement, Autologous Stem Cell Transplantation Trial in Tuebingen (Autologous stemcell transplantation
Active, not recruiting
- Scleroderma
- +2 more
- Autologous stemcell transplantation with CD (cluster of differentiation) 34 selected stem cells
-
Tuebingen, GermanyUniversity Hospital Tuebingen; Department of oncology, hematolog
May 16, 2022
GVHD Trial in Hangzhou (Ruxolitinib+Calcineurin +Methotrexate, Calcineurin +Methotrexate+Mycophenolate mofetil)
Recruiting
- Graft Versus Host Disease
- Ruxolitinib+Calcineurin +Methotrexate
- Calcineurin +Methotrexate+Mycophenolate mofetil
-
Hangzhou, Zhejiang, ChinaThe First Hospital of Zhejiang Medical Colleage Zhejiang Univers
Apr 8, 2021
Allogeneic HCT Using Uniform Conditioning Regimen Regardless of
Unknown status
- Acute Myeloid Leukemia
- allogeneic hematopoietic cell transplantation
-
Seoul, Korea, Republic ofAsan Medical Center
Jul 5, 2019
Myelofibrosis Trial in Houston (Busulfan, Fludarabine, Thymoglobulin (ATG))
Completed
- Myelofibrosis
- Busulfan
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
May 13, 2019
Lupus Erythematosus, Graft-versus-host Disease Trial in Baltimore (drug, radiation, biological)
Terminated
- Lupus Erythematosus
- Graft-versus-host Disease
- Cyclophosphamide
- +6 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sep 19, 2019
ESRD Trial in Stanford, Madison (Immune Tolerance)
Active, not recruiting
- ESRD
- Immune Tolerance
-
Stanford, California
- +1 more
Jun 30, 2022
Graft-versus-host-disease, Prophylaxis Trial in Shanghai (ATG)
Unknown status
- Graft-versus-host-disease
- Prophylaxis
-
Shanghai, Shanghai, ChinaShanghai First People's HOSPITAL
Apr 13, 2019